-->

Final Reminder: See Zacks Top 10 Stocks for $1

Post a Comment
Zacks | Our Research. Your Success.

Don't Miss What Looks To Be a Year-Long Profit Ride

Zacks Member,

I'm reaching out one last time to remind you that we recently posted Zacks Top 10 Stocks for 2023.

Investors who get in on our best long-term buys for the year will position their portfolios for outperformance no matter what the market has in store.

Since 2012, our Top 10 portfolios have TRIPLED the market.

While the S&P 500 gained +287.4%, Zacks Top 10 Stocks skyrocketed +884.4%

The 10 stocks are handpicked strong, successful businesses, not just companies with potential. A few of the new selections include:

Fitness beverage company is floating on $727 million in cash, and it's debt-free. A recent distribution deal with an industry giant looks to accelerate its double and triple-digit growth from each of the last 6 quarters.
This is my play on agriculture, a sector in urgent and ever-increasing demand, especially in developing countries. Products for greater crop yields are driving net sales and revenue skyward.
Spending for education systems was up even before the pandemic. I'm targeting a company with a sterling reputation and best-in-class products. Sweeping past many competitors, it's generating a ton of cash flow.

Act now and be among the first wave of investors to see this coveted list of 10 handpicked stocks for a total cost of only $1.

Bonus Report: Check out the brand-new picks in our Zacks Top 10 Stocks for 2023 and you can also download Zacks' just-released Special Report, 7 Best Stocks for the Next 30 Days. From our proven list of 220 Zacks Rank #1 Strong Buys, our team of experts handpicked these 7 for immediate breakout. So you'll be set to pursue market-beating profits both short and long term.

A word of caution: this opportunity ends at midnight tonight, Tuesday, January 17.

Happy Investing,

Sheraz Mian - signature
Sheraz Mian
Director of Research

Related Posts

There is no other posts in this category.

Post a Comment

Subscribe Our Newsletter